Vanguard Group’s Cabaletta Bio CABA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.25M | Buy |
3,450,727
+606,488
| +21% | +$922K | ﹤0.01% | 3199 |
|
2025
Q1 | $3.94M | Sell |
2,844,239
-23,483
| -0.8% | -$32.5K | ﹤0.01% | 3267 |
|
2024
Q4 | $6.51M | Buy |
2,867,722
+314,012
| +12% | +$713K | ﹤0.01% | 3156 |
|
2024
Q3 | $12.1M | Buy |
2,553,710
+187,653
| +8% | +$886K | ﹤0.01% | 2863 |
|
2024
Q2 | $17.7M | Buy |
2,366,057
+89,835
| +4% | +$672K | ﹤0.01% | 2631 |
|
2024
Q1 | $38.8M | Buy |
2,276,222
+144,291
| +7% | +$2.46M | ﹤0.01% | 2273 |
|
2023
Q4 | $48.4M | Buy |
2,131,931
+163,823
| +8% | +$3.72M | ﹤0.01% | 2202 |
|
2023
Q3 | $30M | Buy |
1,968,108
+246,596
| +14% | +$3.75M | ﹤0.01% | 2372 |
|
2023
Q2 | $22.2M | Buy |
1,721,512
+607,569
| +55% | +$7.84M | ﹤0.01% | 2544 |
|
2023
Q1 | $9.21M | Buy |
1,113,943
+184,754
| +20% | +$1.53M | ﹤0.01% | 2981 |
|
2022
Q4 | $8.59M | Sell |
929,189
-349,362
| -27% | -$3.23M | ﹤0.01% | 3023 |
|
2022
Q3 | $831K | Buy |
1,278,551
+226,713
| +22% | +$147K | ﹤0.01% | 4060 |
|
2022
Q2 | $1.12M | Hold |
1,051,838
| – | – | ﹤0.01% | 4048 |
|
2022
Q1 | $2.14M | Buy |
1,051,838
+147,346
| +16% | +$299K | ﹤0.01% | 3927 |
|
2021
Q4 | $3.43M | Buy |
904,492
+173,711
| +24% | +$658K | ﹤0.01% | 3809 |
|
2021
Q3 | $8.89M | Buy |
730,781
+582
| +0.1% | +$7.08K | ﹤0.01% | 3312 |
|
2021
Q2 | $6.28M | Buy |
730,199
+36,314
| +5% | +$312K | ﹤0.01% | 3471 |
|
2021
Q1 | $7.7M | Buy |
693,885
+38,982
| +6% | +$433K | ﹤0.01% | 3304 |
|
2020
Q4 | $8.17M | Buy |
654,903
+81,573
| +14% | +$1.02M | ﹤0.01% | 3098 |
|
2020
Q3 | $6.22M | Buy |
573,330
+316,053
| +123% | +$3.43M | ﹤0.01% | 3037 |
|
2020
Q2 | $2.87M | Sell |
257,277
-47,116
| -15% | -$525K | ﹤0.01% | 3325 |
|
2020
Q1 | $2.22M | Buy |
304,393
+403
| +0.1% | +$2.94K | ﹤0.01% | 3275 |
|
2019
Q4 | $4.25M | Buy |
+303,990
| New | +$4.25M | ﹤0.01% | 3217 |
|